FIELD: medicine.
SUBSTANCE: methods includes, for instance, gel compositions of prolonged action, which can be injected in desired location and which can ensure controlled release of medical medication during long time period. Compositions include biocompatible polymer, biocompatible solvent, having low solubility in water, forming viscous gel with polymer and limiting water absorption by implant, as well as medication.
EFFECT: systemic or local introduction of medication to patient.
42 cl, 25 ex, 13 tbl, 21 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| DOSED FORMS OF ANESTHETICS FOR ANESTHESIA WITH LONG LIBERATION | 2003 |
|
RU2332985C2 |
| IMPLANTABLE COMPOSITION (VARIANTS) AND METHOD FOR PRODUCTION THEREOF | 2000 |
|
RU2271196C2 |
| PROLONGED RELEASE FORMULATION CONTAINING OCTREOTIDE AND THREE LINEAR POLYMERS OF POLY(LACTIDE-CO-GLYCOLIC ACID) | 2009 |
|
RU2541104C2 |
| HIGH STABILITY PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2427383C2 |
| BIODEGRADABLE THREE-BLOCK POLYESTER/POLYETHYLENE GLYCOL COPOLYMERS POSSESSING LOW MOLECULAR MASS AND REVERSIBLE THERMAL GELLING PROPERTIES | 1999 |
|
RU2232779C2 |
| DELIVERY SYSTEM FOR EXTENDED RELEASE OF CALCIUM CHANNEL BLOCKER | 2010 |
|
RU2575839C2 |
| LONG-ACTING NALTREXONE MICROPARTICLE INJECTABLE COMPOSITIONS | 2019 |
|
RU2817016C2 |
| DELIVERED PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | 2005 |
|
RU2390355C2 |
| THIN-FLUID COMPOSITION FOR INJECTIONS CONTAINING BUPRENORPHINE | 2011 |
|
RU2607498C2 |
| TETRACYCLINE COMPLEXES WITH SUSTAINABLE ACTIVITY | 2019 |
|
RU2806036C2 |
